SCHEMBL4126151

SCHEMBL4126151

CCOC(=O)c1c(OCc2ccccc2)ccnc1Cl

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
PPIA P62937 3/20 0.48
KMT2A Q03164 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
MAPT P10636 4/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
GAA P10253 2/20 0.45
PKM P14618 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.44
HSP90AA1 P07900 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9870377 0.85 CA12 (0.45) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL31517916 0.85 PPIA (0.48) PPIAKMT2ANPC1RAB9AMAPK1
SCHEMBL8523314 0.84 POLB (0.46) POLBPPIAHPGD
SCHEMBL31336328 0.82 KMT2A (0.47) PPIAKMT2ANPC1RAB9AMAPK1
SCHEMBL26601764 0.82 KMT2A (0.47) PPIAKMT2ANPC1RAB9AMAPK1
SCHEMBL10003565 0.81 KMT2A (0.47) PPIAKMT2ANPC1RAB9AMAPK1
SCHEMBL1168812 0.81 GAA (0.44) POLBKMT2ARAB9ASMN1; SMN2KDM4E
SCHEMBL29828897 0.80 CA12 (0.41) POLBNPC1RAB9AMAPK1SMN1; SMN2
SCHEMBL27032911 0.80 CA12 (0.41) POLBNPC1RAB9AMAPK1SMN1; SMN2
SCHEMBL2582045 0.79 RXRA (0.54) PPIAKMT2ANPC1RAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116940552-A Spirocyclic hexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2023-10-24 CN disclosed
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B WYETH (US) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B PTPRS, PTPRO, PTPRM POLB 3952/4885PPIA 453/4885KMT2A 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.